- You are here:
-
Home
- News
News
- Details
- Category: POZ.com
How many people have HIV in the United States? In the world? Here’s a primer on basic statistics.
- Details
- Category: POZ.com
So concluded a pooled analysis of 27 studies mostly conducted in higher income nations.
- Details
- Category: POZ.com
Plan now to watch Black theater and AIDS films, listen to top scientists, and watch 1990s videos—all on December 1.
- Details
- Category: POZ.com
The company also has plans to study monthly islatravir’s efficacy as HIV prevention among men who have sex with men.
- Details
- Category: POZ.com
A study looked at the fat composition of people who switched their antiretrovirals to include an integrase inhibitor.
- Details
- Category: POZ.com
Long-acting injectable cabotegravir for HIV prevention could hit the market for men and women in early 2022.
- Details
- Category: POZ.com
The study in Vietnam examined the effects of an intervention based in cognitive behavioral and motivational enhancement therapy.
- Details
- Category: POZ.com
Gilead Sciences presented findings from several studies of the single-tablet antiretroviral regimen at a recent scientific meeting.
- Details
- Category: POZ.com
You’ve heard about the 90-90-90 HIV targets. But what about measuring quality of life? Bob Leahy wonders about adding a fourth 90.
- Details
- Category: POZ.com
Their global conference also launched the 13 Million Campaign, an effort to get health services to those with HIV and not on meds.
Subcategories
Fundraisers Article Count: 2
Health Article Count: 4
HIV / AIDS Article Count: 4
Partners Article Count: 348
POZ.com Article Count: 347
POZ Stories Article Count: 43
Page 6 of 30
- You are here:
-
Home
- News